StockMarketWire.com - Detection technology supplier Kromek said Monday it had been awarded its first contract for biological-threat detection by the Defense Advanced Research Projects Agency, an agency of the US Department of Defense.
The contract, which was worth $1.99m over a twelve-month period and would commence immediately, was to develop a vehicle-mounted system capable of rapidly identifying the pathogens used in any biological attack, enabling a quicker response and reduced harm to people and the environment, Kromek said.
This project expanded the application of Kromek's technology to include biological-threat detection and builds on the success of the company's work with Defense Advanced Research Projects Agency in nuclear-threat detection using the D3S product family.
Following the initial twelve-month period, the contract could potentially be extended to a multi-year contract for the development of a fully deployable system, Kromek said.
'As the SIGMA programme has begun transitioning to the US Department of Homeland Security, DARPA is turning its focus to add the next generation of biological-threat detection systems,' said Dr Arnab Basu, CEO of Kromek.
'We are delighted to be awarded this additional contract from DARPA, as it expands our relationship with them and broadens our expertise into biological threat detection, adding to our radiological and nuclear threat detection capabilities.'
At 10:03am: [LON:KMK] Kromek Group PLC share price was +1p at 26.5p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.